0001140361-21-020405.txt : 20210609 0001140361-21-020405.hdr.sgml : 20210609 20210609174009 ACCESSION NUMBER: 0001140361-21-020405 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20210607 FILED AS OF DATE: 20210609 DATE AS OF CHANGE: 20210609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ADVENT INTERNATIONAL CORP/MA CENTRAL INDEX KEY: 0001034196 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 211006171 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 6179510555 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII Limited Partnership CENTRAL INDEX KEY: 0001664596 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 211006170 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02119 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-H Limited Partnership CENTRAL INDEX KEY: 0001664582 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 211006163 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-F Limited Partnership CENTRAL INDEX KEY: 0001664584 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 211006164 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-B Limited Partnership CENTRAL INDEX KEY: 0001664592 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 211006169 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-B-3 Limited Partnership CENTRAL INDEX KEY: 0001665974 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 211006166 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-I Limited Partnership CENTRAL INDEX KEY: 0001664748 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 211006162 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-D Limited Partnership CENTRAL INDEX KEY: 0001664766 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 211006165 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-B-1 Limited Partnership CENTRAL INDEX KEY: 0001665956 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 211006168 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-B-2 Limited Partnership CENTRAL INDEX KEY: 0001665962 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 211006167 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syneos Health, Inc. CENTRAL INDEX KEY: 0001610950 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 273403111 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-876-9300 MAIL ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: INC Research Holdings, Inc. DATE OF NAME CHANGE: 20140616 4 1 form4.xml FORM 4 X0306 4 2021-06-07 true 0001610950 Syneos Health, Inc. SYNH 0001034196 ADVENT INTERNATIONAL CORP/MA PRUDENTIAL TOWER, 800 BOYLSTON STREET SUITE 3300 BOSTON MA 02199-8069 true 0001664596 Advent International GPE VIII Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001664592 Advent International GPE VIII-B Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001665956 Advent International GPE VIII-B-1 Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001665962 Advent International GPE VIII-B-2 Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001665974 Advent International GPE VIII-B-3 Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001664766 Advent International GPE VIII-D Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001664584 Advent International GPE VIII-F Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001664582 Advent International GPE VIII-H Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001664748 Advent International GPE VIII-I Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true Class A Common Stock 2021-06-07 4 S 0 6033668 81.2 D 273821 I See Notes Class A Common Stock 2021-06-07 4 S 0 273821 81.2 D 0 I See Notes See Exhibit 99.1 for text of footnote (1). See Exhibit 99.1 for text of footnote (2). See Exhibit 99.1 for text of footnote (3). See Exhibit 99.1 for text of footnote (4). See Exhibit 99.1 for text of footnote (5). Exhibit 99.1 (Footnotes to Form 4) and Exhibit 99.2 (Signatures and Joint Filer Information) are incorporated herein by reference. This Form 4 is the fourth of six Form 4s being filed relating to the same event. This Form 4 has been split into six filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10. Each part will be filed by Designated Filer, Advent International Corporation. See Exhibit 99.2 2021-06-09 EX-99.1 2 brhc10025623_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1

Name and Address of Reporting Person:
Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
Date of Earliest Transaction Required to be Reported:
June 7, 2021
(Month/Day/Year)

Footnotes to Form 4

(1) Represents shares of Class A Common Stock (“Common Stock”) of Syneos Health, Inc. (the “Issuer”) sold in connection with a secondary offering of the Issuer’s Common Stock (the “Offering”) by the following entities: 103,104 shares sold by Advent International GPE VIII-C Limited Partnership (“GPE VIII-C”) and 5,930,564 shares sold by Double Eagle Investor Holdings, L.P. (“Double Eagle Investor Holdings”), of which: 1,230 shares were indirectly sold by Advent Partners GPE VII Limited Partnership, 3,150 shares were indirectly sold by Advent Partners GPE VII 2014 Limited Partnership, 2,909 shares were indirectly sold by Advent Partners GPE VII-A Limited Partnership, 8,634 shares were indirectly sold by Advent Partners GPE VII-A 2014 Limited Partnership, 20,973 shares were indirectly sold by Advent Partners GPE VII (Cayman) Limited Partnership, 7,089 shares were indirectly sold by Advent Partners GPE VII 2014 Cayman Limited Partnership, 5,544 shares were indirectly sold by Advent Partners GPE VII-A (Cayman) Limited Partnership, 28,750 shares were indirectly sold by Advent Partners GPE VII-B (Cayman) Limited Partnership, 5,003 shares were indirectly sold by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership (collectively, the “Advent Partners GPE VII Funds”); 262,573 shares were indirectly sold by Advent International GPE VII-A Limited Partnership, 582,564 shares were indirectly sold by Advent International GPE VII-E Limited Partnership, 45,535 shares were indirectly sold by Advent International GPE VII-H Limited Partnership (collectively, the “GPE VII GP Funds”); 283,686 shares were indirectly sold by Advent International GPE VII Limited Partnership, 808,767 shares were indirectly sold by Advent International GPE VII-B Limited Partnership, 257,016 shares were indirectly sold by Advent International GPE VII-C Limited Partnership, 169,847 shares were indirectly sold by Advent International GPE VII-D Limited Partnership, 74,997 shares were indirectly sold by Advent International GPE VII-F Limited Partnership, 74,997 shares were indirectly sold by Advent International GPE VII-G Limited Partnership (collectively, the “GPE VII GP S.a.r.l. Funds”); 191,122 shares were indirectly sold by Advent International GPE VIII Limited Partnership, 633,077 shares were indirectly sold by Advent International GPE VIII-B Limited Partnership, 224,646 shares were indirectly sold by Advent International GPE VIII-B-1 Limited Partnership, 167,494 shares were indirectly sold by Advent International GPE VIII-B-2 Limited Partnership, 261,547 shares were indirectly sold by Advent International GPE VIII-B-3 Limited Partnership, 88,176 shares were indirectly sold by Advent International GPE VIII-D Limited Partnership, 26,132 shares were indirectly sold by Advent International GPE VIII-F Limited Partnership, 231,506 shares were indirectly sold by Advent International GPE VIII-H Limited Partnership, 215,275 shares were indirectly sold by Advent International GPE VIII-I Limited Partnership, 211,552 shares were indirectly sold by Advent International GPE VIII-J Limited Partnership (collectively, the “GPE VIII GP S.a.r.l. Funds”); 448,303 shares were indirectly sold by Advent International GPE VIII-A Limited Partnership, 98,204 shares were indirectly sold by Advent International GPE VIII-E Limited Partnership, 166,559 shares were indirectly sold by Advent International GPE VIII-G Limited Partnership, 91,664 shares were indirectly sold by Advent International GPE VIII-K Limited Partnership, 90,209 shares were indirectly sold by Advent International GPE VIII-L Limited Partnership (collectively, the “GPE VIII GP Funds”); 44,046 shares were indirectly sold by Advent Partners GPE VIII Cayman Limited Partnership, 5,865 shares were indirectly sold by Advent Partners GPE VIII-A Cayman Limited Partnership, 75,354 shares were indirectly sold by Advent Partners GPE VIII-B Cayman Limited Partnership, 7,392 shares were indirectly sold by Advent Partners GPE VIII Limited Partnership, and 9,177 shares were indirectly sold by Advent Partners GPE VIII-A Limited Partnership (collectively, the “Advent Partners GPE VIII Funds”).

1
(2) Represents shares of Common Stock sold to the Issuer (the “Private Sale”) by the following entities: 4,679 shares sold by GPE VIII-C and 269,142 shares sold by Double Eagle Investor Holdings, of which: 56 were indirectly sold by Advent Partners GPE VII Limited Partnership, 143 shares were indirectly sold by Advent Partners GPE VII 2014 Limited Partnership, 132 shares were indirectly sold by Advent Partners GPE VII-A Limited Partnership, 392 shares were indirectly sold by Advent Partners GPE VII-A 2014 Limited Partnership, 952 shares were indirectly sold by Advent Partners GPE VII (Cayman) Limited Partnership, 322 shares were indirectly sold by Advent Partners GPE VII 2014 Cayman Limited Partnership, 252 shares were indirectly sold by Advent Partners GPE VII-A (Cayman) Limited Partnership, 1,305 shares indirectly sold by Advent Partners GPE VII-B (Cayman) Limited Partnership, 227 shares were indirectly sold by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership; 11,916 shares were indirectly sold by Advent International GPE VII-A Limited Partnership, 26,437 shares were indirectly sold by Advent International GPE VII-E Limited Partnership, 2,067 shares were indirectly sold by Advent International GPE VII-H Limited Partnership; 12,874 shares were indirectly sold by Advent International GPE VII Limited Partnership, 36,703 shares were indirectly sold by Advent International GPE VII-B Limited Partnership, 11,664 shares were indirectly sold by Advent International GPE VII-C Limited Partnership, 7,708 shares were indirectly sold by Advent International GPE VII-D Limited Partnership, 3,404 shares were indirectly sold by Advent International GPE VII-F Limited Partnership, 3,404 shares were indirectly sold by Advent International GPE VII-G Limited Partnership; 8,674 shares were indirectly sold by Advent International GPE VIII Limited Partnership, 28,729 shares were indirectly sold by Advent International GPE VIII-B Limited Partnership, 10,195 shares were indirectly sold by Advent International GPE VIII-B-1 Limited Partnership, 7,601 shares were indirectly sold by Advent International GPE VIII-B-2 Limited Partnership, 11,870 shares were indirectly sold by Advent International GPE VIII-B-3 Limited Partnership, 4,002 shares were indirectly sold by Advent International GPE VIII-D Limited Partnership, 1,186 shares were indirectly sold by Advent International GPE VIII-F Limited Partnership, 10,506 shares were indirectly sold by Advent International GPE VIII-H Limited Partnership, 9,770 shares were indirectly sold by Advent International GPE VIII-I Limited Partnership, 9,601 shares were indirectly sold by Advent International GPE VIII-J Limited Partnership; 20,344 shares were indirectly sold by Advent International GPE VIII-A Limited Partnership, 4,457 shares were indirectly sold by Advent International GPE VIII-E Limited Partnership, 7,559 shares were indirectly sold by Advent International GPE VIII-G Limited Partnership, 4,160 shares were indirectly sold by Advent International GPE VIII-K Limited Partnership, 4,094 shares were indirectly sold by Advent International GPE VIII-L Limited Partnership; 1,999 shares were indirectly sold by Advent Partners GPE VIII Cayman Limited Partnership, 266 shares were indirectly sold by Advent Partners GPE VIII-A Cayman Limited Partnership, 3,420 shares were indirectly sold by Advent Partners GPE VIII-B Cayman Limited Partnership, 335 shares were indirectly sold by Advent Partners GPE VIII Limited Partnership, and 416 shares were indirectly sold by Advent Partners GPE VIII-A Limited Partnership.
 
(3) Following the Offering and the Private Sale, Advent manages funds that collectively own 0 shares, which are represented as follows: 0 shares held directly by GPE VIII-C and 0 shares held directly by Double Eagle Investor Holdings, of which: 0 shares are indirectly owned by Advent Partners GPE VII Limited Partnership, 0shares are indirectly owned by Advent Partners GPE VII 2014 Limited Partnership, 0 shares are indirectly owned by Advent Partners GPE VII-A Limited Partnership, 0 shares are indirectly owned by Advent Partners GPE VII-A 2014 Limited Partnership, 0 shares are indirectly owned by Advent Partners GPE VII (Cayman) Limited Partnership, 0 shares are indirectly owned by Advent Partners GPE VII 2014 Cayman Limited Partnership, 0 shares are indirectly owned by Advent Partners GPE VII-A (Cayman) Limited Partnership, 0 shares are indirectly owned by Advent Partners GPE VII-B (Cayman) Limited Partnership, 0 shares are indirectly owned by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership; 0 shares are indirectly owned by Advent International GPE VII-A Limited Partnership, 0 shares are indirectly owned by Advent International GPE VII-E Limited Partnership, 0 shares are indirectly owned by Advent International GPE VII-H Limited Partnership; 0 shares are indirectly owned by Advent International GPE VII Limited Partnership, 0 shares are indirectly owned by Advent International GPE VII-B Limited Partnership, 0 shares are indirectly owned by Advent International GPE VII-C Limited Partnership, 0 shares are indirectly owned by Advent International GPE VII-D Limited Partnership, 0 shares are indirectly owned by Advent International GPE VII-F Limited Partnership, 0 shares are indirectly owned by Advent International GPE VII-G Limited Partnership; 0 shares are indirectly owned by Advent International GPE VIII Limited Partnership, 0 shares are indirectly owned by Advent International GPE VIII-B Limited Partnership, 0 shares are indirectly owned by Advent International GPE VIII-B-1 Limited Partnership, 0 shares are indirectly owned by Advent International GPE VIII-B-2 Limited Partnership, 0 shares are indirectly owned by Advent International GPE VIII-B-3 Limited Partnership, 0 shares are indirectly owned by Advent International GPE VIII-D Limited Partnership, 0 shares are indirectly owned by Advent International GPE VIII-F Limited Partnership, 0 shares are indirectly owned by Advent International GPE VIII-H Limited Partnership, 0 shares are indirectly owned by Advent International GPE VIII-I Limited Partnership, 0 shares are indirectly owned by Advent International GPE VIII-J Limited Partnership; 0 shares are indirectly owned by Advent International GPE VIII-A Limited Partnership, 0 shares are indirectly owned by Advent International GPE VIII-E Limited Partnership, 0 shares are indirectly owned by Advent International GPE VIII-G Limited Partnership, 0 shares are indirectly owned by Advent International GPE VIII-K Limited Partnership, 0 shares are indirectly owned by Advent International GPE VIII-L Limited Partnership; 0 shares are indirectly owned by Advent Partners GPE VIII Cayman Limited Partnership, 0 shares are indirectly owned by Advent Partners GPE VIII-A Cayman Limited Partnership, 0 shares are indirectly owned by Advent Partners GPE VIII-B Cayman Limited Partnership, 0 shares are indirectly owned by Advent Partners GPE VIII Limited Partnership, and 0 shares are indirectly owned by Advent Partners GPE VIII-A Limited Partnership.

2
(4) Advent is the Sole Member of Double Eagle GP, LLC, which in turn is the General Partner of Double Eagle Investor Holdings. Advent is the Manager of Advent International GPE VII, LLC (“GPE VII LLC”) and Advent International GPE VIII, LLC (“GPE VIII LLC”).

GPE VII, LLC is the General Partner of GPE VII GP S.a.r.l. (“GPE VII GP S.a.r.l.”), GPE VII GP Limited Partnership (“GPE VII GP”), and the Advent Partners GPE VII Funds. GPE VII GP is the General Partner of the GPE VII GP Funds. GPE VII GP S.a.r.l. is the General Partner of the GPE VII GP S.a.r.l. Funds.

GPE VIII LLC is the General Partner of GPE VIII GP Limited Partnership (“GPE VIII GP”), GPE VIII GP S.a.r.l. (“GPE VIII GP S.a.r.l.”), and AP GPE VIII GP Limited Partnership (“AP GPE VIII GP”). GPE VIII GP S.a.r.l. is the General Partner of the GPE VIII GP S.a.r.l. Funds and of GPE VIII-C. GPE VIII GP is the General Partner of the GPE VIII GP Funds. AP GPE VIII GP is the General Partner of the Advent Partners GPE VIII Funds.

(5) Each of the entities named above are referred to herein as “Reporting Persons.” Each Reporting Person disclaims Section 16 beneficial ownership of the shares reported herein except to the extent of its respective pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or any other purpose.


3
 EX-99.2 3 brhc10025623_ex99-2.htm EXHIBIT 99.2
Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
Double Eagle Investor Holdings, L.P.
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

DOUBLE EAGLE INVESTOR HOLDINGS, L.P.
By: Double Eagle GP, LLC, its General Partner
By: Advent International Corporation, its Sole Member

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 1 of 48
Joint Filer Information

Name of Joint Filer:
Double Eagle GP, LLC
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

DOUBLE EAGLE GP, LLC
By: Advent International Corporation, its Sole Member

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 2 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-C Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-C LIMITED PARTNERSHIP
    
By: GPE VIII GP S.à r.l., its General Partner
    
By: Advent International GPE VIII, LLC, its Manager
 /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 3 of 48
Joint Filer Information

Name of Joint Filer:
GPE VIII GP S.à r.l.
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

GPE VIII GP S.à r.l.
    
By: Advent International GPE VIII, LLC, its Manager
 /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 4 of 48
Joint Filer Information

Name of Joint Filer:
GPE VIII GP Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

GPE VIII GP LIMITED PARTNERSHIP
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 5 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII, LLC
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII, LLC
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 6 of 48
Joint Filer Information

Name of Joint Filer:
GPE VII GP S.à r.l.
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

GPE VII GP S.à r.l.

By: Advent International GPE VIII, LLC, its Manager
 /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 7 of 48
Joint Filer Information

Name of Joint Filer:
GPE VII GP Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

GPE VII GP LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 8 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII, LLC
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII, LLC
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 9 of 48
Joint Filer Information

Name of Joint Filer:
AP GPE VIII GP Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

AP GPE VIII GP LIMITED PARTNERSHIP
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 10 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VIII Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 11 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VIII-B Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
  
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII-B CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 12 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VIII Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 13 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VIII-A Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
  
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII-A LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 14 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VIII-A Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII-A CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 15 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-A Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-A LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date

Page 16 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-E Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-E LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 17 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-H Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-H LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 18 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 19 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII 2014 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII 2014 LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 20 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-A Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 21 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-A 2014 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A 2014 LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 22 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 23 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII 2014 Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII 2014 CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 24 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-A Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 25 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-B Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-B CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 26 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-A 2014 Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A 2014 CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 27 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 28 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-B Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 29 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-B-1 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B-1 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 30 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-B-2 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B-2 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 31 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-B-3 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B-3 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 32 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-D Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-D LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 33 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-F Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-F LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 34 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-H Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-H LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 

Page 35 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-I Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-I LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 36 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-J Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-J LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 37 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-A Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-A LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date

Page 38 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-E Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-E LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 39 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-G Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-G LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 40 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-K Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-K LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date

Page 41 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-L Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-L LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 42 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 43 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-B Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-B LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 44 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-C Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-C LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 45 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-D Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-D LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date
 
Page 46 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-F Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-F LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date

Page 47 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-G Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
June 7, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-G LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
   /s/ Jarlyth Gibson  
By: Advent International Corporation, its Manager
  
Jarlyth Gibson, Manager
  

By: /s/ Michael Ristaino  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

June 9, 2021
Date


Page 48 of 48